N-(2-乙氧基乙基)苯胺 | 38004-08-9

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N-(2-乙氧基乙基)苯胺
• 英文名称: N-β-ethoxyethylaniline
• 英文别名: N-(2-ethoxy-ethyl)-aniline；N-(2-Aethoxy-aethyl)-anilin；2-Anilino-1-aethoxy-aethan；N-(2-Ethoxyethyl)aniline
• CAS: 38004-08-9
• 化学式: C₁₀H₁₅NO
• mdl: MFCD09035692
• 分子量: 165.235
• InChiKey: JLYJJRHBGXOWSQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  21.3
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2922199090

反应信息

• 作为反应物：
  描述：

  N-(2-乙氧基乙基)苯胺 生成 N-(2-ethoxy-ethyl)-N-phenyl-hydrazine
  参考文献：
  名称：

  Derivatives of 2-n-methyl-1, 2, 3, 4-tetrahydro-gamma-carbolines

  摘要：

  公开号：

  US02759943A1
• 作为产物：
  描述：

  N-苯基乙醇胺 在 potassium-<2-anilino ethylate> 、 镍 、 苯 作用下， 120.0~150.0 ℃ 、1.57 MPa 条件下， 生成 N-(2-乙氧基乙基)苯胺
  参考文献：
  名称：

  Schostakowskii; Tschekulaewa, Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1955, p. 146,150; engl. Ausg. S. 127, 131

  摘要：

  DOI：

文献信息

• [EN] BICYCLIC HETEROCYCLE DERIVATIVES AND USE THEREOF AS GPR119 MODULATORS<br/>[FR] DÉRIVÉS HÉTÉROCYCLIQUES BICYCLIQUES ET LEUR UTILISATION EN TANT QUE MODULATEURS DE GPR119
  申请人：SCHERING CORP

  公开号：WO2009143049A1

  公开（公告）日：2009-11-26

  The present invention relates to Bicyclic Heterocycle Derivatives of formula (I), compositions comprising a Bicyclic Heterocycle Derivative, and methods of using the Bicyclic Heterocycle Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of GPR1 19 in a patient.

  本发明涉及公式（I）的双环杂环衍生物，包含双环杂环衍生物的组合物，以及使用双环杂环衍生物治疗或预防患者的肥胖、糖尿病、代谢紊乱、心血管疾病或与GPR119活性相关的疾病的方法。
• Pyrazole compounds and their use as antidiabetes agents
  申请人：Takagi Masaki

  公开号：US20070032529A1

  公开（公告）日：2007-02-08

  The present invention provides a pyrazole compound that has liver glycogen phosphorylase inhibitory activity and is useful as a therapeutic or prophylactic agent for diabetes, the pyrazole compound represented by the following general formula (I): wherein Ring Q represents an aryl or heteroaromatic group, R 1 represents a hydrogen atom, a halogen atom, a C 1-6 alkyl group or a C 1-6 alkoxy group, R 2 represents a halogen atom, a C 1-6 alkyl group, a C 1-6 alkoxy group or an azido group, R 3 represents a halogen atom, a hydroxyl group, a C 1-6 alkyl group, a halo C 1-6 alkyl group, a C 1-6 alkoxy group, an azido group, an amino group, an acylamino group or a C 1-6 alkylsulfonylamino group, R 4 and R 5 are identical with or different from each other and represent a hydrogen atom, a substituted or unsubstituted C 1-6 alkyl group, a C 3-8 cycloalkyl group, a substituted or unsubstituted saturated heterocyclic group, a substituted or unsubstituted aryl group, a C 7-14 aralkyl group, a heteroaromatic group, or the like, or a pharmacologically acceptable salt thereof.

  本发明提供了一种具有肝糖原磷酸化酶抑制活性的吡唑化合物，用作糖尿病的治疗或预防剂，所述吡唑化合物由以下通用式（I）表示：其中环Q代表芳基或杂芳基，R1代表氢原子、卤原子、C1-6烷基或C1-6烷氧基，R2代表卤原子、C1-6烷基、C1-6烷氧基或偶氮基，R3代表卤原子、羟基、C1-6烷基、卤代C1-6烷基、C1-6烷氧基、偶氮基、氨基、酰胺基或C1-6烷基磺酰胺基，R4和R5彼此相同或不同，代表氢原子、取代或未取代的C1-6烷基、取代或未取代的C3-8环烷基、取代或未取代的饱和杂环基、取代或未取代的芳基、C7-14芳基烷基、杂芳基等，或其药理学上可接受的盐。
• Process for preparing diphenylalkene derivatives
  申请人：KANZAKI PAPER MANUFACTURING CO., LTD.

  公开号：EP0257591A2

  公开（公告）日：1988-03-02

  A process for preparing a diphenylalkene derivative of the formula [II] which comprises oxidizing a diphenylalkanoic acid derivative of the formula [I] wherein R₁ and R₂ are each substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl or substituted or unsubstituted aryl, R₁ and R₂ may form a heteroring together therewith or with an adjacent benzene ring, R₃, R₄, R₅, R₆, R₇, R₈, R₉, R₁₀ and R₁₁ are each hydrogen atom, halogen atom, substituted or unsubstituted alkyl, substituted or unsubstituted hydroxyl or substituted or unsubstituted amino, R₁₂ and R₁₃ are each hydrogen atom or substituted or unsubstituted alkyl, X is carboxyl, amide, ester or halide thereof.

  一种制备式[II]二苯基烷烃衍生物的工艺 其中包括氧化式[I]的二苯基烷酸衍生物 其中 R₁ 和 R₂ 各自为取代或未取代的烷基、取代或未取代的烯基、取代或未取代的炔基、取代或未取代的环烷基、取代或未取代的芳烷基或取代或未取代的芳基，R₁ 和 R₂ 可与之或与相邻的苯环一起形成杂环、R₃、R₄、R₅、R₆、R₇、R₈、R₉、R₁₀ 和 R₁₁ 各为氢原子、卤素原子、取代或未取代的烷基、取代或未取代的羟基或取代或未取代的氨基，R₁₂ 和 R₁₃ 各为氢原子或取代或未取代的烷基，X 为羧基、酰胺、酯或其卤化物。
• PYRAZOLE COMPOUND AND THERAPEUTIC AGENT FOR DIABETES COMPRISING THE SAME
  申请人：Japan Tobacco, Inc.

  公开号：EP1884513A1

  公开（公告）日：2008-02-06

  The present invention provides a pyrazole compound that has liver glycogen phosphorylase inhibitory activity and is useful as a therapeutic or prophylactic agent for diabetes, the pyrazole compound represented by the following general formula (I): wherein Ring Q represents an aryl or heteroaromatic group, R1 represents a hydrogen atom, a halogen atom, a C1-6 alkyl group or a C1-6 alkoxy group, R2 represents a halogen atom, a C1-6 alkyl group, a C1-6 alkoxy group or an azido group, R3 represents a halogen atom, a hydroxyl group, a C1-6 alkyl group, a halo C1-6 alkyl group, a C1-6 alkoxy group, an azido group, an amino group, an acylamino group or a C1-6 alkylsulfonylamino group, R4 and R5 are identical with or different from each other and represent a hydrogen atom, a substituted or unsubstituted C1-6 alkyl group, a C3-8 cycloalkyl group, a substituted or unsubstituted saturated heterocyclic group, a substituted or unsubstituted aryl group, a C7-14 aralkyl group, a heteroaromatic group, or the like, or a pharmacologically acceptable salt thereof.

  本发明提供了一种具有肝糖原磷酸化酶抑制活性并可用作糖尿病治疗或预防剂的吡唑化合物，该吡唑化合物由以下通式(I)表示： 其中环 Q 代表芳基或杂芳基，R1 代表氢原子、卤素原子、C1-6 烷基或 C1-6 烷氧基，R2 代表卤素原子、C1-6 烷基、C1-6 烷氧基或叠氮基，R3 代表卤素原子、羟基、C1-6 烷基、卤代 C1-6 烷基、C1-6 烷氧基、叠氮基、氨基、酰氨基或酰胺基、R4 和 R5 彼此相同或不同，代表氢原子、取代或未取代的 C1-6 烷基、C3-8 环烷基、取代或未取代的饱和杂环基、取代或未取代的芳基、C7-14 芳基、杂芳基或类似基团，或其药理学上可接受的盐。
• Schostakowskii; Tschekulaewa, Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1955, p. 146,150; engl. Ausg. S. 127, 131
  作者：Schostakowskii、Tschekulaewa

  DOI：——

  日期：——